β-Amyloid (Aβ) proteins, which are the pathological hallmark of Alzheimer’s disease (AD), begin to deposit at the pre-clinical stage of the AD continuum and are known to induce tau pathology along the disease course [1, 2]. The gene discussed is MAPT; the disease is Alzheimer disease.